A phase II trial of arzoxifene, a selective estrogen response modulator, in patients with recurrent or advanced endometrial cancer - Concepedia

Concepedia

Publication | Closed Access

A phase II trial of arzoxifene, a selective estrogen response modulator, in patients with recurrent or advanced endometrial cancer

81

Citations

20

References

2003

Year

D. Scott McMeekin, Alan N. Gordon, Jeffrey M. Fowler, Allen S. Melemed, Richard E. Buller, Thomas J. Burke, J. Bloss, Paul Sabbatini

Gynecologic Oncology

Advanced Endometrial CancerOncologyPhase Ii TrialMedicineGynecologyPharmacotherapyPharmacologyGynecology OncologyEndocrine-related CancerMenopause Hormone Therapy

References

	Year	Citations

Page 1

Page 1